Table 3(B).
Age at LCH diagnosis |
||||||||
---|---|---|---|---|---|---|---|---|
≤18 years |
>18 years |
|||||||
Associated Malignancy |
Associated Malignancy |
|||||||
precedes | concurrent | follows | Total | precedes | concurrent | follows | Total | |
Lymphomas | ||||||||
Hodgkin | 2 | 1 | 4 | 7 | 12 | 17 | 3 | 32 |
Non-Hodgkin | 2 | 1 | 4 | 7 | 6 | 13 | 4 | 23+2 |
Large B-cell | 1 | - | 3 | 4 | - | 3 | - | 3 |
Immunoblastic | - | - | - | - | - | 1 | - | 1 |
Follicular | - | - | - | - | 3 | 1 | 1 | 5 |
Follicular grade 2 | - | - | - | - | - | 3 | - | 3 |
Follicular grade 1 | 1 | - | - | 1 | - | - | - | - |
Lymphoblastic | - | - | - | - | - | 2 | - | 2 |
T-cell lymphoblastic | - | 1 | - | 1 | - | 3 | 2 | 5 |
Multiple myeloma | - | - | - | - | 2 | - | - | 2 |
Unspecified | - | - | 1 | 1 | 1 | - | 1 | 2 |
Histiocytic sarcoma | - | - | - | +1 | - | - | 1 | 1+1 |
PTLD | - | - | 1 | 1 | - | - | - | - |
Total | 4 | 2 | 9 | 15+1 | 18 | 30 | 8 | 56+3 |
Legend:
PTLD: Post transplant proliferative disorder.
+n: number of malignancies subsequent to the first AM.